Apollo Care, Llc: Semaglutide 12.5mg (2.5mg/ml)
Recall Summary Apollo Care, LLC is recalling Semaglutide 12.5mg (2.5mg/mL) injection vials nationwide because the product contains small particles of nylon/polyamide and silk material. The recall affects prescription semaglutide vials distributed across all U.S. states and Washington, D.C. This is classified as a Class II recall, meaning the product could cause adverse health effects.
- Recalling firm
- Apollo Care, LLC
- Product
- SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05
- Reason
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-29
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the U.S
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/46c2566d-ca51-4ec1-a339-3e4286a16e7d